Reagents and conditions: vii) 2-Bromo-6-(dimethoxymethyl)pyridine (7), Pd(PPh 3 ) 4 , THF, 2 M Na 2 CO 3 , 60 °C, 4 d. viii) pTSA, THF, H 2 O, 50 °C, 3 h. ix) 4-Nitrobenzohydrazide (21), aniline, CH 2 Cl 2 , r.t., 16 h. x) TFA, CH 2 Cl 2 , r.t., 1 h. xi) 3-Amino-4-(((S)-((1S,2R,4S,5R)-5-ethylquinuclidin-2-yl)(7-methoxynaphthalen-1-yl)methyl)amino)cyclobut-3-ene-1,2-dione (4), DMF, Et 3 N, MeOH, r.t., 16 h.
S5
xii) 3-Bromo-2-(dimethoxymethyl)pyridine (6), Pd(PPh 3 ) 4 , THF, 2 M Na 2 CO 3 , 60 °C, 4 d. xiii) 3-Nitrobenzohydrazide (22), aniline, CH 2 Cl 2 , r.t., 16 h. xiv) 3-amino-4-(((R)-((1S,2S,4S,5R)-5-ethylquinuclidin-2-yl)(7-methoxynaphthalen-1-yl)methyl)amino)cyclobut-3-ene-1,2-dione (5), DMF, Et 3 N, MeOH, r.t., 16 h.
7,
S1 6, S2 4, S3 5, S3 21 S4 and 22 S5 were synthesized according to literature procedures.
S1. tert-Butyl (3-bromo-4-(decyloxy)benzyl)carbamate
To a stirred suspension of 3-bromo-4-hydroxybenzonitrile (5.00 g, 25.2 mmol) and caesium carbonate (8.21 g, 25.2 mmol) in MeCN (100 ml) was added 1-bromodecane (5.53 g, 25.0 mmol). The suspension was then heated to reflux for 16 h then the reaction was cooled to r.t., and partitioned between Et 2 O (500 ml) and 1 M NaOH (aq) (500 ml). The organic phase was washed with 1 M NaOH (aq) (500 ml), dried over MgSO 4 , filtered and concentrated in vacuo to afford the crude product. The crude product was then dissolved in THF (50 ml) and cooled to 0 °C. To this stirred solution, BH 3 .THF (1 M in THF, 40 ml) was added dropwise. The reaction was heated to reflux for 16 h then cooled to 0 °C and quenched with H 2 O (2 ml) followed by 1 M NaOH (aq) (2 ml). The solvent was removed in vacuo and the residue dissolved in CH 2 Cl 2 (200 ml). This solution was then washed with 2 M NaOH (aq) (200 ml), dried over MgSO 4 , filtered and concentrated in vacuo to afford the crude product. The crude was then dissolved in CH 2 Cl 2 (200 ml) and diisopropylethylamine (7.5 ml). To this was added di-tert-butyl dicarbonate (4.20 g, 19.2 mmol) all at once. The reaction was stirred at r.t. for 1 h and the solvent removed in vacuo. Imidazole (3.00 g, 44.0 mmol) was added to the residue, which was then dissolved in EtOH (75 ml), and stirred at r.t. for 5 min. The solvent removed in vacuo and the residue partitioned between CHCl 3 and 1 M HCl (aq) . The organic phase was dried over MgSO 4 , filtered, and the solvent removed in vacuo to afford the crude product. Purification by flash column chromatography [EtOAc:PE 7:3] afforded S1 (5.51 g, 12.1 mmol, 50%) as a pale yellow oil. 155.6, 154.8, 132.4, 132.3, 127.6, 113.2, 112.3, 79.6, 69.3, 43.7 ,31.9, 29.6, 29.6, 29.3, 29.1, 28.4, 26.0, 22.7, 14 
H NMR (600 MHz
,
S2. tert-Butyl ((6-(decyloxy)-4'-hydroxy-[1,1'-biphenyl]-3-yl)methyl)carbamate
Bromide S1 (6.00 g, 13.6 mmol) was dissolved in DMF (60 ml) and 2 M Na 2 CO 3(aq) (20 ml). The reaction was sparged with argon for 15 minutes, then 4-hydroxyphenylboronic acid (3.50 g, 25.4 mmol) and Pd(dppf) (800 mg, 0.980 mmol) were added. 155.5, 154.8, 131.0, 131.0, 131.0, 130.7, 130.1, 129.8, 127.5, 114.9, 112.8, 79.6, 68.7, 44.4, 32.0, 29.7, 29.7, 29.5, 29.4, 28.6, 26.2, 22.8, 14.3 
S3. 5'-(((tert-Butoxycarbonyl)amino)methyl)-2'-(decyloxy)-[1,1'-biphenyl]-4-yl trifluoromethanesulfonate
To a stirred solution of S2 (5.50 g, 12.1 mmol) in DMF (150 ml) and diisopropylethylamine (8 ml) was added N-phenyl-bis(trifluoromethanesulfonimide) (5.00 g, 14.0 mmol). The reaction was stirred at r.t. for 16 h before the solvent was removed in vacuo. The residue was partitioned between CH 2 Cl 2 (200 ml) and 2 M HCl (aq) (200 ml). The organic phase was washed with 2 M NaOH (aq) (200 ml) then LiCl (sat) , dried over MgSO 4 , filtered, and concentrated in vacuo. The crude product was purified by flash column chromatography [EtOAc:PE 1:9] to furnish S3 (6.72 g, 11.8 mmol, 97%) as a yellow oil. 148.5, 139.1, 131.6, 131.4, 129.8, 128.6, 128.3, 123.9, 120.6, 118.8 (q, J = 320 Hz), 112.5, 79.1, 68.6, 43.9, 31.9, 29.6, 29.5, 29.3, 29.2, 29.1, 28.1, 26.1, 22.7, 13. 155.9, 155.4, 141.3, 134.3, 131.0, 130.8, 130.2, 128.9, 128.0, 112.7, 83.7, 79.5, 68.7, 44.2, 31.9, 29.6, 29.6, 29.3, 29.3, 29.2, 29.1, 28.5, 26.0, 24.9, 22.7, 14 
S4. tert-Butyl
To a stirred solution of 3 (170 mg, 0.301 mmol) in THF (5 ml) and 2 M Na 2 CO 3 (aq) (2 ml) was added 2-Bromo-6-(dimethoxymethyl)pyridine (7) (160 mg, 0.689 mmol). The solution was sparged with argon for 15 min. Pd(PPh 3 ) 4 (120 mg, 0.104 mmol) was added, and the reaction heated to 60 °C under argon for 4 days. The reaction was cooled to r.t. and partitioned between EtOAc (50 ml) and 0.1 M EDTA (aq) (50 ml 156.5, 155.9, 155.5, 139.2, 137.5, 134.5, 131.1, 130.5, 130.1, 129.9, 128.0, 126.6, 120.3, 119.3, 112.7, 104.9, 79.5, 68.7, 54.2, 44.2, 31.9, 29.6, 29.6, 29.3, 29.3, 29.2, 28.4, 28.1, 22.7, 14 
tert-Butyl ((6-(decyloxy)-4'-(6-formylpyridin-2-yl)-[1,1'-biphenyl]-3-yl)methyl)carbamate
To a stirred solution of S4 (78.0 mg, 0.132 mmol) in THF (3 ml) was added H 2 O (100 µl) and p-toluenesulfonic acid (78.0 mg, 0.411 mmol). The reaction was heated under argon to 50 °C for 3 h. The reaction was partitioned between CH 2 Cl 2 (30 ml) and 2 M NaOH (aq) (30 ml). The organic phase was dried over Na 2 SO 4 , filtered and concentrated in vacuo. 194.1, 157.8, 155.9, 155.5, 152.7, 139.9, 137.8, 136.5, 131.1, 130.2, 130.2, 130.2, 128.2, 126.5, 124.4, 119.7, 112.7, 79.5, 68.7, 44.2, 38.1, 31.9, 29.6, 29.5, 29.3, 29.3, 29.2, 28.4, 26.1, 22.7, 14 
tert-Butyl (E)-((6-(decyloxy)-4'-(6-((2-(4-nitrophenyl)hydrazono)methyl)pyridin-2-yl)-[1,1'-biphenyl]-3-yl)methyl)carbamate
To a stirred solution of 9 (740 mg, 1.36 mmol) in CH 2 Cl 2 (100 ml) was added 4-nitrobenzohydrazide (296 mg, 1.63 mmol, 21) and aniline (6.33 mg, 0.0680 mmol). 156.5, 156.2, 155.0, 152.3, 149.8, 140.9, 140.3, 140.2, 139.5, 136.7, 132.9, 130.2, 129.7, 129.5, 129.1, 128.3, 127.3, 126.1, 124.4, 123.1, 113.4, 68.7, 41.8, 31.6, 29.4, 29.2, 29.2, 29.0, 29.0, 28.7, 28.7, 26.0, 22.5, 14.3 
N'-((E)-(6-(2'-(Decyloxy)-5'-(((2-(((S)-((1S,2R,4S,5R)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methyl)amino)-3,4-dioxocyclobutyl)amino)methyl)-[1,1'-biphenyl]-4-yl)pyridin-2-yl)methylene)-4-nitrobenzohydrazide

S10
Hydrazide 11 (51.1 mg, 0.0721 mmol) was dissolved in CH 2 Cl 2 (4 ml) and TFA (1 ml) was added. The reaction was stirred at r.t. for 1 h and concentrated in vacuo with the addition of toluene (5 ml). The residue was azeotroped 5 × with toluene:CH 2 Cl 2 (1:1, 10 ml). The crude residue was dissolved in DMF (2 ml), MeOH (2 ml) and Et 3 N (0.5 ml), then 4 (85.2 mg, 0.195 mmol) was added. The reaction was stirred at r.t. for 16 h, concentrated in vacuo, and purified by preparatory thin layer chromatography (4 × 500 µm, eluted with Et 3 N:MeOH:CH 2 Cl 2 0.1:1:10) to afford 1 (46 mg, 0.0455 mmol, 63%) as a yellow powder. 182.5, 162.3, 156.2, 155.6, 153.4, 149.9, 149.8, 148.2, 144.8, 140.9, 140.2, 139.4, 139.3, 138.5, 137.0, 132.0, 131.3, 130.5, 130.0, 129.8, 129.5, 129.4, 129.2, 128.7, 127.3, 126.6, 125.8, 124.2, 123.4, 121.4, 119.3, 113.6, 101.9, 68.6, 59.1, 56.2, 48.6, 40.7, 31.7, 31.6, 29.4, 29.3, 29.2, 29.2, 29.1, 29.1, 29.0, 29.0, 28.9, 25.9, 25.9, 22.5, 22.5, 14.4, 14.3 
H NMR
S5. tert-Butyl ((6-(decyloxy)-4'-(2-(dimethoxymethyl)pyridin-3-yl)-[1,1'-biphenyl]-3-yl)methyl)carbamate
To a stirred solution of 3 (170 mg, 0.301 mmol) in THF (5 ml) and 2 M Na 2 CO 3(aq) (2 ml) was added 6 (160 mg, 0.689 mmol). The solution was sparged with argon for 15 min, Pd(PPh 3 ) 4 (120 mg, 0.104 mmol) was added, and the reaction heated to 60 °C under argon for 4 days. The reaction was cooled to r.t. and partitioned between EtOAc (50 ml) and 0.1 M EDTA (aq) (50 ml 157.3, 156.6, 155.9, 155.5, 139.1, 137.6, 137.3, S11 131.0, 130.5, 130.1, 129.9, 128.0, 126.6, 120.2, 119.2, 112.7, 105.0, 68.8, 54.1, 44.2, 31.9, 29.6, 29.6, 29.5, 29.3, 29.3, 29.1, 28.4, 26.1, 22.7, 14 
tert-Butyl (E)-((6-(decyloxy)-4'-(2-((2-(3-nitrobenzoyl)hydrazono)methyl)pyridin-3-yl)-[1,1'-biphenyl]-3-yl)methyl)carbamate
N'-((E)-(3-(2'-(decyloxy)-5'-(((2-(((R)-((1S,2S,4S,5R)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methyl)amino)-3,4-dioxocyclobutyl)amino)methyl)-[1,1'-biphenyl]-4-yl)pyridin-2-yl)methylene)-3-nitrobenzohydrazide
10 (43.7 mg, 0.617 mmol) was dissolved in CH 2 Cl 2 (4 ml) and TFA (1 ml) was added. The reaction was stirred at r.t. for 1 h and concentrated in vacuo with the addition of toluene (5 ml). The residue was azeotroped 5 × with toluene:CH 2 Cl 2 (1:1, 10 ml). The crude residue was dissolved in DMF (2 ml), MeOH (2 ml) and Et 3 N (0.5 ml), then 5 (85 mg, 0.195 mmol) was added. The reaction was stirred at r.t. for 16 h, concentrated in vacuo, and purified by preparatory thin layer chromatography (4 × 500 µm, eluted with Et 3 N:MeOH:CH 2 Cl 2 0.1:1:10) to afford 2 (33.1 mg, 0.327 mmol, 53%) as a yellow powder. 182.4, 182.1, 167.0, 157.9, 155.1, 147.8, S13 147.7, 146.7, 145.2, 144.3, 141.2, 139.6, 138.5, 137.9, 137.3, 134.2, 133.8, 131.6, 131.1, 130.2, 129.9, 129.7, 129.6, 129.4, 129.3, 128.9, 127.5, 126.0, 125.6, 125.2, 122.5, 122.1, 113.2, 101.3, 68.2, 59.0, 55.6, 49.0, 48.1, 46.4, 31.3, 29.1, 29.0, 28.9, 28.9, 28.8, 28.7, 28.7, 28.6, 28.6, 25.7, 25.6, 25.4, 22.1, 13.9, 13.9 
H NMR
Catalysis tests Addition of malonitrile to chalcone to form S6
Malonitrile 12 (1.0 mg, 0.015 mmol), chalcone S7 (32 mg, 0.15 mmol) and catalyst 1 or 2 (0.75 mg, 0.75 μmol) were dissolved in CDCl 3 (0.7 ml). Conversion was measured periodically by 1 H NMR spectroscopy and comparison with authentic spectra of starting materials and product.
Upon completion, the crude was purified by TLC, and the chirality of the product ascertained by HPLC (chiralpak IC, 90:10 Hexane:iPrOH, major enantiomer produced by catalyst 1 t r = 18.4 min, for catalyst 2 t r = 29.9 min).
Addition of 1,4-dithiane-2,5-diol to chalcone to form S8
1,4-dithiane-2,5-diol S9 (2.3 mg, 0.015 mmol), chalcone S7 (32 mg, 0.15 mmol) and catalyst 1 or 2 (0.75 mg, 0.75 μmol) were dissolved in toluene (0.7 ml) then heated to 50 °C. Conversion was measured periodically by 1 H NMR spectroscopy and comparison with authentic spectra of starting materials and product. Upon completion, the crude was purified by TLC, and the chirality of the product ascertained by HPLC (chiralpak IA, 90:10 Hexane:iPrOH, major enantiomer produced by catalyst 1 t r = 13.6 min, for catalyst 2 t r = 19.3 min).
Addition of malonitrile to (E)-1-(furan-2-yl)-3-phenylprop-2-en-1-one to form 14
Malonitrile 12 (1.0 mg, 0.015 mmol), (E)-1-(furan-2-yl)-3-phenylprop-2-en-1-one 13 (30 mg, 0.15 mmol) and catalyst 1 or 2 (0.75 mg, 0.75 μmol) were dissolved in CDCl 3 (0.7 ml). Conversion was measured periodically by 1 H NMR spectroscopy and comparison with authentic spectra of starting materials and product. Upon completion, the crude was purified by TLC, and the chirality of the product ascertained by HPLC (chiralpak IA, 90:10 Hexane:iPrOH, major enantiomer produced by catalyst 1 t r = 19.9 min, for catalyst 2 t r = 23.9 min).
Addition of diethyl malonate to trans-β-nitrostyrene to form S10
Diethyl malonate S11 (24 mg, 0.15 mmol), trans-β-nitrostyrene S12 (2.2 mg, 0.015 mmol) and catalyst 1 or 2 (3.75 mg, 3.75 μmol) were dissolved in CDCl 3 (0.7 ml). Conversion was measured periodically by 1 H NMR spectroscopy and comparison with authentic spectra of starting materials and product. Upon completion, the crude was purified by TLC, and the chirality of the product ascertained by HPLC (chiralpak IA, 90:10 Hexane:iPrOH, major enantiomer produced by catalyst 1 t r = 13.7 min, for catalyst 2 t r = 18.4 min).
Addition of diethyl malonate to trans-β-nitrostyrene to form S13
1,3-Diphenylpropane-1,3-dione S14 (3.4 mg, 0.015 mmol), trans-β-nitrostyrene S12 (22 mg, 0.15 mmol) and catalyst 1 or 2 (3.75 mg, 3.75 μmol) were dissolved in CDCl 3 (0.7 ml). Conversion was measured periodically by 1 H NMR spectroscopy and comparison with authentic spectra of starting materials and product. Upon completion, the crude was purified by TLC, and the chirality of the product ascertained by HPLC (chiralpak IA, 90:10 Hexane:iPrOH, major enantiomer produced by catalyst 1 t r = 18.5 min, for catalyst 2 t r = 36.8 min).
Addition of malonitrile to (E)-1-(furan-2-yl)-3-phenylprop-2-en-1-one to form S15
2-(Methoxymethoxy)malononitrile S16 (8.0 mg, 0.063 mmol, prepared according to literature procedure) S10 , (E)-1-(furan-2-yl)-3-phenylprop-2-en-1-one 13 (62 mg, 0.32 mmol) and catalyst 1 or 2 (3.2 mg, 3.2 μmol) were dissolved in CDCl 3 (1 ml). Upon completion, the crude was purified by PTLC, furnishing a colourless oil (24.1 mg, 0.0744 mmol, 74%) and the chirality of the product ascertained by HPLC (chiralpak IA, 90:10 Hexane:iPrOH, major enantiomer produced by catalyst 1 t r = 12.1 min, for catalyst 2 t r = 9.8 min 184.4, 152.2, 146.8, 133.9, 129.6, 129.3, 128.9, 117.6, 112.7, 96.5, 70.0, 57.5, 49.1, 38.4 
Optimisation of light switching conditions for catalyst 1
The degree of isomerisation was monitored by following the integral ratio of the E and Z states of hydrazone proton H(55) (at c. 12 ppm and c. 16 ppm, see characterisation for full numbering).
A brief initial screen of light sources showed a 395 nm source to be the most efficient in promoting hydrazone isomerization. Initially problems with decomposition, particularly hydrazone hydrolysis, were observed. This could be prevented by the addition of molecular sieves, which also improved the E:Z ratio achieved. A significant improvement in final switching ratio was achieved by the addition of EtOAc to the solvent mixture (pure EtOAc could not be used due to insufficient solubility). Increasing the concentration of solution was deleterious to conversion. The timescale of switching could be accelerated to 20 min of irradiation by increasing the power and using CH 2 Cl 2 :EtOAc as solvent. This switching system also alleviated the previously observed decomposition, obviating the need for molecular sieves. 
Optimisation of thermal switching of catalyst 1
Initial isomerization of catalyst 1 focused on pure thermal switching. More polar solvents were found to promote isomerization, and pleasing ratios could be obtained in DMF at 90 °C. However, the extended reaction time and high temperature required prompted us to search for effective acid catalysed switching conditions. The addition of TFA to EtOAc allowed virtually quantitative switching after one hour. 
in situ Switching Experiments
Procedure for switching of catalyst state during the course of reaction Malonitrile (1.0 mg, 0.015 mmol), (E)-1-(furan-2-yl)-3-phenylprop-2-en-1-one (9 mg, 0.045 mmol) and catalyst 2 (0.75 mg, 0.75 μmol) were dissolved in CDCl 3 (0.7 ml). Conversion was measured periodically by 1 H NMR spectroscopy and comparison with authentic spectra of starting materials and product. After a given time, the reaction was diluted with 10 ml Et 2 O. The precipitate was collected via syringe filtration, and dissolved in CH 2 Cl 2 . The filtrate was stored at − 20 °C for the duration of the switching procedure. The relevant heat or light switch was performed on the catalyst, followed by aqueous extraction with saturated Na 2 CO 3 (aq) . After drying, the catalyst was recombined with the diluted reaction mixture. Solvent was removed in vacuo whilst the flask was cooled to 0 °C. The reaction mixture was immediately dissolved in CDCl 3 (0.7 ml) and monitored by NMR. This process was repeated using the alternate switching conditions after a suitable time had passed. No erosion of stereochemistry in the product was observed, as compared to the continuous reaction. Figure S1 . Relative reactivity of ON and OFF states of catalyst 2 towards the addition of malonitrile to chalcone 22 by starting with the OFF state (left) or ON state (right, solid lines are a guide to the eye).
A full switching cycle could be carried out during this reaction, starting from either 'ON' or 'OFF' catalyst, using 3.5 mol% of 2 (initial E:Z ratio 99:1 (ON) or 2:98 (OFF)). After 6 h the E-to-Z, or vice versa, stimulus was applied (0.1% CF 3 CO 2 H, 60 min, 50 °C or 395 nm, 700 mW, 20 min) and the reaction continued. After 24 h (for initially OFF 2) or 21 h (for initially ON 2) the opposing stimulus was applied reverting catalyst 2 to its initial state. 
HPLC Traces
Formation of S6 using catalyst 1 (Chiralpak IC, 90:10 Hexane:iPrOH, 1mL/min).
Formation of S6 using catalyst 2 (Chiralpak IC, 90:10 Hexane:iPrOH, 1mL/min).
Formation of S8 using catalyst 1 (Chiralpak IA, 90:10 Hexane:iPrOH, 1mL/min). 
